PERFORMANCE CHARECTERISTICS OF TURBO VENTILATOR: A REVIEW

Turbo ventilator is an alternative to motor driven ventilating systems. The rooftop turbo ventilator is now widely accepted for industrial ventilation as well becomes important ventilation feature which is used for ventilation of commercial, residential and many institutional buildings. It works effectively at very low wind speeds hence always functional. Many researchers found that performance of turbo ventilator depends on its various operating parameters and environmental conditions. Therefore, study of turbo ventilators in details has become the focus area of research. In this paper detailed study about the current improvements and future scope of the turbo ventilator is done. The results of analytical and the experimental works are analyzed by considering its performance for the various applications

REVIEW ON THERMAL SEEDS IN MAGNETIC HYPERTHERMIA THERAPY

We present the short review on Magnetic nanoparticle specifically for biomedical application. This study shows the overview on magnetic material properties and its biocompatibility. Moreover focusing on engineering aspect of hyperthermia

Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

Background: General anaesthesia (GA) during endovascular thrombectomy has been associated with worse patient outcomes in observational studies compared with patients treated without GA. We assessed functional outcome in ischaemic stroke patients with large vessel anterior circulation occlusion undergoing endovascular thrombectomy under GA, versus thrombectomy not under GA (with or without sedation) versus standard care (ie, no thrombectomy), stratified by the use of GA versus standard care. Methods: For this meta-analysis, patient-level data were pooled from all patients included in randomised trials in PuMed published between Jan 1, 2010, and May 31, 2017, that compared endovascular thrombectomy predominantly done with stent retrievers with standard care in anterior circulation ischaemic stroke patients (HERMES Collaboration). The primary outcome was functional outcome assessed by ordinal analysis of the modified Rankin scale (mRS) at 90 days in the GA and non-GA subgroups of patients treated with endovascular therapy versus those patients treated with standard care, adjusted for baseline prognostic variables. To account for between-trial variance we used mixed-effects modelling with a random effect for trials incorporated in all models. Bias was assessed using the Cochrane method. The meta-analysis was prospectively designed, but not registered. Findings: Seven trials were identified by our search; of 1764 patients included in these trials, 871 were allocated to endovascular thrombectomy and 893 were assigned standard care. After exclusion of 74 patients (72 did not undergo the procedure and two had missing data on anaesthetic strategy), 236 (30%) of 797 patients who had endovascular procedures were treated under GA. At baseline, patients receiving GA were younger and had a shorter delay between stroke onset and randomisation but they had similar pre-treatment clinical severity compared with patients who did not have GA. Endovascular thrombectomy improved functional outcome at 3 months both in patients who had GA (adjusted common odds ratio (cOR) 1·52, 95% CI 1·09–2·11, p=0·014) and in those who did not have GA (adjusted cOR 2·33, 95% CI 1·75–3·10, p<0·0001) versus standard care. However, outcomes were significantly better for patients who did not receive GA versus those who received GA (covariate-adjusted cOR 1·53, 95% CI 1·14–2·04, p=0·0044). The risk of bias and variability between studies was assessed to be low. Interpretation: Worse outcomes after endovascular thrombectomy were associated with GA, after adjustment for baseline prognostic variables. These data support avoidance of GA whenever possible. The procedure did, however, remain effective versus standard care in patients treated under GA, indicating that treatment should not be withheld in those who require anaesthesia for medical reasons

Measurement of Ds + production and nuclear modification factor in Pb-Pb collisions at √sNN = 2.76 TeV

The production of prompt D s + mesons was measured for the first time in collisions of heavy nuclei with the ALICE detector at the LHC. The analysis was performed on a data sample of Pb-Pb collisions at a centre-of-mass energy per nucleon pair, sNN−−−√ , of 2.76 TeV in two different centrality classes, namely 0–10% and 20–50%. D s + mesons and their antiparticles were reconstructed at mid-rapidity from their hadronic decay channel D s +  → ϕπ +, with ϕ → K−K+, in the transverse momentum intervals 4 < p T < 12GeV/c and 6 < p T < 12 GeV/c for the 0–10% and 20–50% centrality classes, respectively. The nuclear modification factor R AA was computed by comparing the p T-differential production yields in Pb-Pb collisions to those in proton-proton (pp) collisions at the same energy. This pp reference was obtained using the cross section measured at s√=7 TeV and scaled to s√=2.76 TeV. The R AA of D s + mesons was compared to that of non-strange D mesons in the 10% most central Pb-Pb collisions. At high p T (8 < p T < 12 GeV/c) a suppression of the D s + -meson yield by a factor of about three, compatible within uncertainties with that of non-strange D mesons, is observed. At lower p T (4 < p T < 8 GeV/c) the values of the D s + -meson R AA are larger than those of non-strange D mesons, although compatible within uncertainties. The production ratios D s + /D0 and D s + /D+ were also measured in Pb-Pb collisions and compared to their values in proton-proton collisions